Samsara BioCapital

Suggest edits

Also headquartered in Palo Alto

Companies in the same industry

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 17

Portfolio

Portfolio Tracker

Add info

A2 Biotherapeutics

Biotechnology +1

Total funding
$71.5M in 1 rounds from 8 investors

By Samsara BioCapital
$71.5M Series B in Oct, 2020

Allakos Inc

Health Care +1

Total funding
$280.8M in 4 rounds from 10 investors

By Samsara BioCapital
$100M Series B in Dec, 2017

Atreca, Inc.

Biotechnology

Total funding
$308.8M in 4 rounds from 9 investors

By Samsara BioCapital
$125M Series C in Sep, 2018

Autobahn Therapeutics

Biotechnology +1

Total funding
$76M in 1 rounds from 10 investors

By Samsara BioCapital
$76M Series B in Jun, 2020

Bolt Biotherapeutics, Inc.

Biotechnology +1

Total funding
$93.5M in 1 rounds from 9 investors

By Samsara BioCapital
$93.5M Series C in Jul, 2020

Chinook Therapeutics

Biotechnology +1

Total funding
$106M in 1 rounds from 12 investors

By Samsara BioCapital
$106M Post-IPO equity in Aug, 2020

Delfi Diagnostics

Health Care +1

Total funding
$100M in 1 rounds from 10 investors

By Samsara BioCapital
$100M Series A in Jan, 2021

ElevateBio

Biotechnology

Total funding
$320M in 2 rounds from 12 investors

By Samsara BioCapital
$170M Series B in Mar, 2020

Exo Therapeutics

Biotechnology +1

Total funding
$78M in 1 rounds from 8 investors

By Samsara BioCapital
$78M Series B in Oct, 2021

Flame Biosciences

Health Care +1

Total funding
$100M in 1 rounds from 10 investors

By Samsara BioCapital
$100M Undisclosed in Oct, 2020

FORMA Therapeutics

Biotechnology

Total funding
$129.5M in 3 rounds from 8 investors

By Samsara BioCapital
$100M Series D in Dec, 2019

Neurogastrx

Health Care +2

Total funding
$60M in 1 rounds from 7 investors

By Samsara BioCapital
$60M Series B in Aug, 2021

Notch Therapeutics

Biotechnology +1

Total funding
$85M in 1 rounds from 7 investors

By Samsara BioCapital
$85M Series A in Feb, 2021

Palvella Therapeutics

Biotechnology +1

Total funding
$57.5M in 3 rounds from 9 investors

By Samsara BioCapital
$45M Series C in May, 2020

Recursion Pharmaceuticals

Biotechnology +1

Total funding
$339.6M in 8 rounds from 29 investors

By Samsara BioCapital
$239M Series D in Sep, 2020

Sutro Biopharma

Biotechnology

Total funding
$164.2M in 6 rounds from 12 investors

By Samsara BioCapital
$85.4M Series E in Jul, 2018

Want to see the complete list?
Go Pro!

Index

By TNW